Regeneron Pharmaceuticals Inc. buy Barclays PLC
Start price
11.07.24
/
50%
€989.60
Target price
11.07.25
€1,101.8
Performance (%)
-50.80%
End price
12.07.25
€486.90
Summary
This prediction ended on 12.07.25 with a price of €486.90. The BUY prediction by Barclays_PLC for Regeneron Pharmaceuticals Inc. performed very badly with a performance of -50.80%. Barclays_PLC has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Dividends of €1.72 are taken into consideration when calculating the performance. Barclays_PLC has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | -2.342% | -2.342% | 13.774% |
| iShares Core DAX® | -2.796% | -1.396% | -0.221% |
| iShares Nasdaq 100 | -6.352% | -0.407% | 28.998% |
| iShares Nikkei 225® | -6.943% | -0.275% | 48.214% |
| iShares S&P 500 | -3.410% | 0.396% | 20.281% |
Comments by Barclays_PLC for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target raised by analysts at Barclays PLC from $1,050.00 to $1,200.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€651.80
06.03.26
06.03.26
€794.33
06.03.27
06.03.27
-18.10%
16:19
16:19
Stopped prediction by Barclays_PLC for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€604.40
30.04.26
30.04.26
€785.87
30.04.27
30.04.27
-11.67%
16:19
16:19
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€775.00
01.11.24
01.11.24
€981.82
01.11.25
01.11.25
-26.71%
02.11.25
02.11.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€871.00
23.10.24
23.10.24
€1,001.5
23.10.25
23.10.25
-43.20%
24.10.25
24.10.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€990.00
02.08.24
02.08.24
€1,116.5
02.08.25
02.08.25
-51.29%
03.08.25
03.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€873.50
23.01.24
23.01.24
€938.09
23.01.25
23.01.25
-24.40%
24.01.25
24.01.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€705.50
07.08.23
07.08.23
€817.83
07.08.24
07.08.24
37.94%
08.08.24
08.08.24